Jacob Fog Bentzon

Aarhus University

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (14)

Michael Maeng

Aarhus University Hospital

DENMARK

View details

Maria Paola Santini

Assistant Professor of Medicine

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Hans Erik Bøtker

Aarhus University

DENMARK

View details

Daniel Morales Cano

Assistant professor

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Stine Gunnersen

Aarhus University

DENMARK

View details

Charlotte Brandt Sørensen

Assoc. prof.

Aarhus University

DENMARK

View details

Victoria McGilligan

Lecturer

University of Ulster

UNITED KINGDOM

View details

Julian Albarran-Juarez

Aarhus University

DENMARK

View details

Peter Loof Møller

Aalborg University

DENMARK

View details

Lotte Bjerre Knudsen

Chief Scientific Advisor

Novo Nordisk A/S

DENMARK

View details

Palle Duun Rohde

Aalborg University

DENMARK

View details

Laust Dupont Rasmussen

Aarhus University

DENMARK

View details

Laura Alonso-Herranz

Aarhus University

DENMARK

View details

Johan Björkegren

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jacob Fog Bentzon

Research Interests

Contact this professor

Articles (17)

Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease

Smooth muscle cells clonally expand in a murine carotid allograft model complicated by immune reactions to reporter transgenes

Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

Conditional deletion of Ccl2 in smooth muscle cells does not reduce early atherosclerosis in mice

Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes

Capacity for LDL (Low-Density Lipoprotein) Retention Predicts the Course of Atherogenesis in the Murine Aortic Arch

Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry

Severe arterial injury heals with a complex clonal structure involving a large fraction of surviving smooth muscle cells

Combining Polygenic and Proteomic Risk Scores With Clinical Risk Factors to Improve Performance for Diagnosing Absence of Coronary Artery Disease in Patients With De Novo Chest Pain

Mechanisms of fibrous cap formation in atherosclerosis

Semaglutide treatment attenuates vessel remodelling in ApoE−/− mice following vascular injury and blood flow perturbation

New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume

Single-Cell Behavior in Closure of the Arterial Duct

Analysis of 18 F-Sodium Fluoride Positron Emission Tomography Signal Sources in Atherosclerotic Minipigs Shows Specific Binding of 18 F-Sodium Fluoride to Plaque Calcifications

Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development

The phenotypic responses of vascular smooth muscle cells exposed to mechanical cues

Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype

Collaborators (14)

Michael Maeng

Maria Paola Santini

Hans Erik Bøtker

Daniel Morales Cano

Stine Gunnersen

Charlotte Brandt Sørensen

Victoria McGilligan

Julian Albarran-Juarez

Peter Loof Møller

Lotte Bjerre Knudsen

Palle Duun Rohde

Laust Dupont Rasmussen

Laura Alonso-Herranz

Johan Björkegren

Make your next move.